论文部分内容阅读
目的:探讨应用奥扎格雷钠联合降纤酶治疗脑血栓形成的临床疗效。方法:选择2013年9月-2014年9月来本院就诊的患者60例,采用随机数字表法分为观察组与对照组,对照组采用常规治疗,观察组在常规治疗的基础上采用奥扎格雷钠联合降纤酶的治疗方式,比较两组治疗效果。结果:观察组神经功能缺损评分与不良反应发生情况明显低于对照组,总有效率96.7%明显高于对照组,差异具有统计学意义(P<0.01)。结论:临床治疗中采用奥扎格雷钠联合降纤酶治疗脑血栓形成能够降低患者神经功能缺损评分,提高临床治疗效果,降低不良反应发生率。
Objective: To investigate the clinical efficacy of ozagrel combined with defibrase in the treatment of cerebral thrombosis. Methods: Sixty patients from our hospital from September 2013 to September 2014 were selected and divided into observation group and control group by random number table method. The control group was treated by conventional therapy. The observation group adopted the conventional therapy Zagre sodium combined defibrase treatment, the treatment effect of two groups were compared. Results: The scores of neurological deficits and adverse reactions in the observation group were significantly lower than those in the control group. The total effective rate was 96.7%, which was significantly higher than that in the control group (P <0.01). Conclusion: Ozagrel combined with defibrase in clinical treatment of cerebral thrombosis can reduce neurological deficit score, improve the clinical effect and reduce the incidence of adverse reactions.